Wolters Kluwer to Acquire AgileMD for Up to $100M, With $40M Paid Upfront

A Price Capped at $100M, With $40M Paid at Signing

Wolters Kluwer Health, the health division of Wolters Kluwer, has signed an agreement to acquire AgileMD, a medical technology company based in San Francisco. The price could reach $100 million. It consists of an initial payment of $40 million and a deferred additional payment.

This balance is not guaranteed to the sellers: it depends on the achievement of certain performance targets. The portion of the price actually paid will therefore depend on how the business develops after the acquisition. The $100 million figure is a ceiling, not a committed amount.

The transaction has not yet been completed. It remains subject to the usual closing conditions and other administrative approvals. Wolters Kluwer anticipates completion in the first quarter of 2027, or earlier.

AgileMD provides healthcare professionals with clinical decision support tools based on artificial intelligence. Its offering combines interactive clinical pathways and predictive analytics, with the aim of standardizing care practices and helping to reduce mortality.

The company markets two products. Pathways integrates local institutional recommendations into the electronic patient record, in order to harmonize care and measure outcomes. eCART is a real-time clinical surveillance engine, cleared by the U.S. Food and Drug Administration (FDA), designed to help limit deaths.

Founded in 2011, AgileMD is led by its two co-founders, Borna Safabakhsh, chief executive officer, and Dana Edelson, physician and chief medical officer. All of its 23 employees will join Wolters Kluwer Health.

An Effect Deemed Not Significant on the Group's Adjusted Earnings

According to Wolters Kluwer, AgileMD is expected to reach annual recurring revenue (ARR) of $7 million by the end of 2026. This metric measures subscription revenue on an annualized basis.

At the group level, the size of the transaction remains limited. Wolters Kluwer generated annual revenue of €6.1 billion in 2025, and management indicates that the acquisition is expected to have a non-significant effect on its adjusted earnings.

The group has also set a profitability criterion. It anticipates that the acquisition will generate, within three to five years, a return on invested capital (ROIC) equal to or greater than its weighted average cost of capital (WACC) after tax, which it sets at 8%.

The structure of the price is consistent with this objective: the contingent component links part of the amount paid to the target's future performance, and limits the amount paid upfront to $40 million.

This acquisition follows shortly after other portfolio moves. On October 30, 2026, Wolters Kluwer had announced the planned sale of its consumer tax software business in Germany to Buhl Data Service GmbH, for €40 million, as part of the refocusing of its Tax & Accounting division.

On November 4, 2026, the group reported 6% organic growth over the first nine months and confirmed its annual targets.

AgileMD to Extend UpToDate to Hospital Tools

The industrial stakes concern UpToDate, the group's clinical reference knowledge base. Since its launch in September 2025, the UpToDate Expert AI version has been adopted by more than 2,700 hospitals and health systems in the United States, representing more than 95% of U.S. customers of the UpToDate Enterprise edition.

Yaw Fellin, Senior Vice President of Wolters Kluwer Clinical Solutions, believes that AgileMD will facilitate “the extension of UpToDate to integrated workflows, local recommendations and new digital health applications.” He adds: “With AgileMD, we are well positioned to help health systems better care for patients and get more value from their technology investments.”

For Borna Safabakhsh, leveraging UpToDate's capabilities will allow AgileMD to “accelerate and streamline the development and maintenance of more advanced clinical pathways” designed for complex medical decisions.